Tubulointerstitial Nephropathies in HIV-Infected Patients over the Past 15 Years
Open Access
- 1 June 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 8 (6), 930-938
- https://doi.org/10.2215/cjn.10051012
Abstract
Background and objectives The therapy and outcome of HIV infection have dramatically changed over the last 15 years, resulting in a change in renal complications. This study analyzed the characteristics of HIV-infected patients and biopsy-proven tubulointerstitial nephropathies to define disease patterns and therapeutic implications. Design, setting, participants, & measurements A clinico-pathologic retrospective study of 59 consecutive renal biopsies showing predominant tubular and/or interstitial lesions in HIV-infected patients referred to the nephrology department between 1995 and 2011 was performed. HIV-associated nephropathy and vascular diseases were excluded from the study. Results Tubulointerstitial nephropathies accounted for 26.6% of 222 native renal biopsies performed in HIV-infected patients. Two pathologic groups were analyzed, tubulopathy and interstitial nephritis, which represented 49% and 51% of tubulointerstitial nephropathies, respectively. Most patients presented with AKI (76.3%) and high-grade proteinuria (57.7%). Drug-related nephrotoxicity was the leading cause (52.5%). Alternative etiologies included infections (15.2%), dysimmune disorders (8.5%), malignancies (3.4%), and chronic (10.2%) and acute (10.2%) tubulointerstitial nephropathies of undetermined origin. Tubulopathy was strongly associated with antiretroviral drug toxicity (75.9%) and mostly caused by tenofovir (55.2%), which was associated with proximal tubular dysfunction (87.5%), overt Fanconi’s syndrome (37.5%), and nephrogenic diabetes insipidus (12.5%). Interstitial nephritis was associated with a broader spectrum of pathologic lesions and etiologies. Conclusions In this series, tubulointerstitial nephropathies accounted for 26.6% of renal diseases in HIV-infected patients. Considering the therapeutic implications of diagnoses of drug toxicity, infection, and dysimmune syndromes, this study underscores the importance of monitoring renal parameters in HIV-infected patients and points to the relevance of kidney biopsy to allow an accurate diagnosis.This publication has 56 references indexed in Scilit:
- Integration of Antiretroviral Therapy with Tuberculosis TreatmentThe New England Journal of Medicine, 2011
- Acute dialysis in HIV-positive patients in Cape Town, South AfricaNephrology, 2010
- Acute interstitial nephritisKidney International, 2010
- Characteristics of Patients with HIV and Biopsy-Proven Acute Interstitial NephritisClinical Journal of the American Society of Nephrology, 2010
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis TherapyThe New England Journal of Medicine, 2010
- The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapyKidney International, 2009
- Acute interstitial nephritis associated with atazanavir, a new protease inhibitorAmerican Journal of Kidney Diseases, 2004
- Immune Reconstitution Inflammatory SyndromeMedicine, 2002
- Acute interstitial nephritis in the elderly: a report from the UK MRC glomerulonephritis register and a review of the literatureNephrology Dialysis Transplantation, 1998
- Associated Focal and Segmental Glomerulosclerosis in the Acquired Immunodeficiency SyndromeThe New England Journal of Medicine, 1984